Jun 17, 2020

Striving for Consensus on the Optimal Management of Metastatic Non-Small Cell Lung Cancer — Part 1: A roundtable discussion featuring Drs John Heymach, Leora Horn, Melissa Johnson and Benjamin Levy.

• Biomarker assessment for patients with metastatic non-small cell lung cancer (NSCLC) (00:00)
• Selection of first-line...

Jun 17, 2020

Striving for Consensus on the Optimal Management of Metastatic Non-Small Cell Lung Cancer — Part 2: A roundtable discussion featuring Borghaei, Brahmer, Garon and Govindan.

• Genomic profiling for patients with metastatic NSCLC; role of liquid biopsy (00:00)
• Therapeutic approach for patients with NSCLC with no...

Apr 30, 2020

Biomarker Assessment and Targeted Treatment of Nonsquamous Non-Small Cell Lung Cancer — A roundtable discussion with clinical investigators Drs Justin F Gainor, Matthew Gubens, Geoffrey R Oxnard and Heather Wakelee and general medical oncologists Drs Isaac Levy and Estelamari Rodriguez regarding biomarker analysis and...

Apr 30, 2020

Biomarker Assessment and Targeted Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC) — Slide Presentation 1: Overview of Targeted Treatment for Metastatic NSCLC — Dr Gubens
CME information and select...

Apr 30, 2020

Biomarker Assessment and Targeted Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC) — Slide Presentation 2: Liquid Biopsy in NSCLC: How to Interpret and Apply Results in Clinical Practice — Dr Oxnard.
CME information and select...